Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bristol-Myers Squibb

47.12
-0.8000-1.67%
Volume:2.70M
Turnover:127.83M
Market Cap:95.91B
PE:18.95
High:48.15
Open:47.96
Low:47.09
Close:47.92
52wk High:63.33
52wk Low:42.96
Shares:2.04B
Float Shares:2.03B
Volume Ratio:0.86
T/O Rate:0.13%
Dividend:2.46
Dividend Rate:5.22%
EPS(TTM):2.49
EPS(LYR):-4.4144
ROE:29.32%
ROA:8.34%
PB:5.50
PE(LYR):-10.67

Loading ...

Bristol-Myers Squibb’s New Phase 3 Trial: A Potential Game-Changer in Lung Cancer Treatment?

TIPRANKS
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Stevanato Group (STVN), Galapagos (GLPG) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Aug 04

Guggenheim Reaffirms Their Hold Rating on Bristol-Myers Squibb (BMY)

TIPRANKS
·
Aug 04

Balanced Outlook on Bristol-Myers Squibb: Strong Earnings Amid Strategic Uncertainties

TIPRANKS
·
Aug 04

Why Drug Prices for Some Big Medicines Will Remain High for a Longer Time -- WSJ

Dow Jones
·
Aug 03

Bristol Myers (BMY) Q2 EPS Jumps 36%

Motley Fool
·
Aug 02

Bristol-Myers Squibb Is Maintained at Neutral by Citigroup

Dow Jones
·
Aug 02

Bristol-Myers Squibb (BMY) Receives a Buy from J.P. Morgan

TIPRANKS
·
Aug 02

Bristol-Myers Squibb’s Latest Lung Cancer Study: Key Insights for Investors

TIPRANKS
·
Aug 02

Rothschild & Co Redburn Adjusts Bristol-Myers Squibb PT to $49 From $48, Keeps Neutral Rating

MT Newswires Live
·
Aug 02

Bristol-Myers Squibb’s SUCCESSOR-2 Study: A Potential Game-Changer in Multiple Myeloma Treatment

TIPRANKS
·
Aug 02

JPMorgan Cuts Price Target on Bristol-Myers Squibb to $65 From $67, Maintains Overweight Rating

MT Newswires Live
·
Aug 01

Bristol-Myers Squibb Co : UBS Cuts Target Price to $46 From $52

THOMSON REUTERS
·
Aug 01

Bloomsbury Publishing Announces Share Purchase by Key Stakeholder

TIPRANKS
·
Aug 01

Bristol-Myers Squibb Co : Bmo Cuts Target Price to $47 From $53

THOMSON REUTERS
·
Aug 01

Bristol-Myers Squibb Co : Citigroup Cuts Target Price to $47 From $51

THOMSON REUTERS
·
Aug 01

Cautious Hold Rating on Bristol-Myers Squibb Amid Strong Q2 Results and Future Challenges

TIPRANKS
·
Aug 01

BMY Earnings: Bristol Myers Squibb Stock Rises on Q2 Beats & Strong 2025 Guidance

TIPRANKS
·
Aug 01

Trump Threatens Pharma Giants over ‘Abusive’ Drug Prices

TIPRANKS
·
Aug 01

Trump posts letters calling on drug company CEOs to lower prices

TIPRANKS
·
Aug 01